Zobrazeno 1 - 10
of 40
pro vyhledávání: '"George, Mo"'
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Painful vaso-occlusive crisis (VOC) remains the most common reason for presenting to the Emergency Department and hospitalization in patients with sickle cell disease (SCD). Although two new agents have been approved by the Food and Drug Adm
Externí odkaz:
https://doaj.org/article/bb03e3ec7b68407f8cc1d543f71e14cf
Autor:
Tim Jang, George Mo, Connor Stewart, Leen Khoury, Natalie Ferguson, Ogechukwu Egini, John Muthu, Dibyendu Dutta, Moro Salifu, Seah H Lim
Publikováno v:
Cell Transplantation, Vol 30 (2021)
Hematopoietic stem cell transplant (HSCT) is the only cure for patients with sickle cell disease (SCD). Although most SCD patients experience progressive end-organ damage and shortened lifespans, not all patients follow the same disease course, tempo
Externí odkaz:
https://doaj.org/article/1481e2dfc747401aa9e672bd12abcdda
Autor:
Aimee C Talleur, Brandon M Triplett, Haneen Shalabi, Bonnie Yates, Nirali N Shah, George Mo, Hao-Wei Wang, Shilpa A Shahani, Michael G Douvas, Katherine R Calvo, Jack F Shern, Sridhar Chaganti, Katharine Patrick, Young Song, Terry J Fry, Xiaolin Wu, Javed Khan, Rebecca A Gardner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Immunotherapeutic strategies targeting B-cell acute lymphoblastic leukemia (B-ALL) effectively induce remission; however, disease recurrence remains a challenge. Due to the potential for antigen loss, antigen diminution, lineage switch or development
Externí odkaz:
https://doaj.org/article/9165dfbe9bda40b7991cff5cb81c8857
Publikováno v:
The Prostate.
Autor:
David A. Scheinberg, Scott W. Lowe, Neal Rosen, Jedd D. Wolchok, Taha Merghoub, Ralph J. Garippa, Aaron Y. Chang, Qing Xiang, David Ulmert, Casey A. Jarvis, James E. Han, Patrizia Mondello, George Mo, Ron S. Gejman, Sadna Budhu, Eusebio Manchado, Claire Y. Oh, Elliott J. Brea
The major histocompatibility complex I (MHC-1) presents antigenic peptides to tumor-specific CD8+ T cells. The regulation of MHC-I by kinases is largely unstudied, even though many patients with cancer are receiving therapeutic kinase inhibitors. Reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b921a8e6261436f07b913c855c672ef
https://doi.org/10.1158/2326-6066.c.6548366.v1
https://doi.org/10.1158/2326-6066.c.6548366.v1
Autor:
David A. Scheinberg, Scott W. Lowe, Neal Rosen, Jedd D. Wolchok, Taha Merghoub, Ralph J. Garippa, Aaron Y. Chang, Qing Xiang, David Ulmert, Casey A. Jarvis, James E. Han, Patrizia Mondello, George Mo, Ron S. Gejman, Sadna Budhu, Eusebio Manchado, Claire Y. Oh, Elliott J. Brea
Supplementary Table S1. MSK Memorial Hospital IMPACT genomic sequencing data for the JMN human mesothelioma cell line. Supplementary Table S2. Sh RNA used. Supplementary Table S3. List of antibodies used. Supplementary Table S4. Top 5 negative regula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dadc032d18ddc5f2b090d8031720c10
https://doi.org/10.1158/2326-6066.22537259
https://doi.org/10.1158/2326-6066.22537259
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Journal of Translational Medicine
Journal of Translational Medicine
Painful vaso-occlusive crisis (VOC) remains the most common reason for presenting to the Emergency Department and hospitalization in patients with sickle cell disease (SCD). Although two new agents have been approved by the Food and Drug Administrati
Autor:
George Mo, Sang Yun Lee, David G. Coffey, Valentin Voillet, IIan Kirsch, Damian J. Green, Raphael Gottardo, David G. Maloney, Oliver W. Press, Brian G. Till
Publikováno v:
Blood. 140:7460-7461
Autor:
Thomas J. Gardner, J. Peter Lee, Christopher M. Bourne, Dinali Wijewarnasuriya, Nihar Kinarivala, Keifer G. Kurtz, Broderick C. Corless, Megan M. Dacek, Aaron Y. Chang, George Mo, Kha M. Nguyen, Renier J. Brentjens, Derek S. Tan, David A. Scheinberg
Publikováno v:
Nat Chem Biol
Chimeric Antigen Receptor (CAR)-T cells represent a major breakthrough in cancer therapy, wherein a patient’s own T cells are engineered to recognize a tumor antigen, resulting in activation of a local cytotoxic immune response. However, CAR-T cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fffdaf19be59b3d07f97fbb8d3caee33
https://europepmc.org/articles/PMC9152922/
https://europepmc.org/articles/PMC9152922/
Autor:
Connor Stewart, Ogechukwu Egini, Seah H Lim, George Mo, Leen Khoury, John Muthu, Tim Jang, Moro O. Salifu, Natalie Ferguson, Dibyendu Dutta
Publikováno v:
Cell Transplantation, Vol 30 (2021)
Cell Transplantation
Cell Transplantation
Hematopoietic stem cell transplant (HSCT) is the only cure for patients with sickle cell disease (SCD). Although most SCD patients experience progressive end-organ damage and shortened lifespans, not all patients follow the same disease course, tempo